Fresenius SE KGaA (XSWX:FRE) Ending Cash Position: CHF1,874 Mil (As of Mar. 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF36.15
GF Value CHF33.50
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Ending Cash Position?

Fresenius SE KGaA XSWX:FRE 71 Ending Cash Position is CHF1,874 Mil as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.50 (Fairly Valued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA's Ending Cash Position for the quarter that ended in Mar. 2026 was CHF1,874 Mil.

Fresenius SE KGaA's quarterly Ending Cash Position declined from Sep. 2025 (CHF2,209 Mil) to Dec. 2025 (CHF1,479 Mil) but then increased from Dec. 2025 (CHF1,479 Mil) to Mar. 2026 (CHF1,874 Mil).

Fresenius SE KGaA's annual Ending Cash Position declined from Dec. 2023 (CHF2,416 Mil) to Dec. 2024 (CHF2,131 Mil) and declined from Dec. 2024 (CHF2,131 Mil) to Dec. 2025 (CHF1,479 Mil).

Fresenius SE KGaA Ending Cash Position Related Terms

Fresenius SE KGaA Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Ending Cash Position Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,876.43 2,712.89 2,416.16 2,130.50 1,479.02

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,280.17 1,149.92 2,208.90 1,479.02 1,874.05
XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Fresenius SE KGaA's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2129.422+-650.398
=1,479

Fresenius SE KGaA's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1443.535+430.512
=1,874

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of CHF1,874 Mil mean?
Fresenius SE KGaA (XSWX:FRE) has a Ending Cash Position of CHF1,874 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Ending Cash Position too high?
Fresenius SE KGaA's current Ending Cash Position is CHF1,874 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Ending Cash Position compare to HCA and THC?
Fresenius SE KGaA's Ending Cash Position of CHF1,874 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Ending Cash Position is CHF1,874 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.50, compared to a current price of CHF36.15 — trading 7.9% above its estimated fair value. The current Ending Cash Position is CHF1,874 Mil. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Ending Cash Position is CHF1,874 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF36.15 is trading 7.9% above its estimated GF Value™ of CHF33.50. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Ending Cash Position: CHF1,874 Mil
  • GF Value™: CHF33.50 vs. price of CHF36.15 (7.9% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF36.15
Price
CHF33.50
GF Value